Indivumed is a physician-led, integrated global oncology company for personalized medicine with the world’s premier high-content tumor database and highest-quality biobank. Our range of diverse services and products is tailored to customers’ needs in translational and clinical research and molecular diagnostics. Our reputation for excellence is built on our standard operating procedures for biospecimen collection: “Indivumed Standard”. With approximately 200 employees across Europe, North America, and Asia, we are an internationally minded, future-oriented company with an ambitious growth strategy, which includes the development of a global cancer database solution based on high-throughput molecular data.